| Předmět: |
|
| Zdroj: |
Drug Week; 3/31/2023, p1193-1193, 1p |
| Abstrakt: |
Keywords: Antimetabolites; Antineoplastics; Antivirals; Biomarkers; Bladder Cancer; Cancer; Diagnostics and Screening; Drugs and Therapies; Gemcitabine Therapy; Health and Medicine; Immunosuppressive Agents; Oncology; Pharmaceuticals; Radiation-Sensitizing Agents EN Antimetabolites Antineoplastics Antivirals Biomarkers Bladder Cancer Cancer Diagnostics and Screening Drugs and Therapies Gemcitabine Therapy Health and Medicine Immunosuppressive Agents Oncology Pharmaceuticals Radiation-Sensitizing Agents 1193 1193 1 03/27/23 20230331 NES 230331 2023 MAR 28 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Fresh data on bladder cancer are presented in a new report. According to the news editors, the research concluded: "In addition, the expression of JHDM1D/JHDM1D-AS1 indicated potential prognostic value in the progression of bladder tumors.". [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
